Key result
Catheter ablation for tachyarrhythmias in LVAD recipients requires multidisciplinary care to mitigate risks like iatrogenic ASDs.
Why the study?
With prolonged follow-up and a lack of donor hearts in durable LVAD recipients, managing concomitant tachyarrhythmias has become an increasingly critical clinical need.
Catheter ablation for tachyarrhythmias in LVAD recipients presents unique technical challenges and safety risks, necessitating a multidisciplinary team approach.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary ablation protocols in LVAD recipients; extends observational data but leaves open need for prospective trials.
The demand for durable left ventricular assist devices (LVADs) has been increasing worldwide in tandem with the rising population of advanced heart failure patients. Especially in cases of destination therapy, instead of bridges to transplantation, LVADs require a lifelong commitment. With the increase in follow-up periods after implantation and given the lack of donor hearts, the need for managing concomitant tachyarrhythmias has arisen. Atrial and ventricular arrhythmias are documented in approximately 20% to 50% of LVAD recipients during long-term device support, according to previous registries. Atrial arrhythmias, primarily atrial fibrillation, generally exhibit good hemodynamic tolerance; therefore, catheter ablation cannot be easily recommended due to the risk of a residual iatrogenic atrial septal defect that may lead to a right-to-left shunt under durable LVAD supports. The clinical impacts of ventricular arrhythmias, mainly ventricular tachycardia, may vary depending on the time periods following the index implantation. Early occurrence after the operation affects the hospitalization period and mortality; however, the late onset of ventricular tachycardia causes varying prognostic impacts on a case-by-case basis. In cases of hemodynamic instability, catheter ablation utilizing a trans-septal approach is necessary to stabilize hemodynamics. Nonetheless, in some cases originating from the intramural region or the epicardium, procedural failure may occur with the endocardial ablation. Specialized complications associated with the state of LVAD support should be carefully considered when conducting procedures. In LVAD patients, electrophysiologists, circulatory support specialists, and surgeons should collaborate as an integrated team to address the multifaceted issues related to arrhythmia management.
No takes yet. Share an insight, caveat, or question.
Kataoka et al. (2023) conducted a review in Tachyarrhythmias in Left Ventricular Assist Device (LVAD) recipients. Catheter ablation was evaluated. Catheter ablation for tachyarrhythmias, which occur in 20% to 50% of LVAD recipients, requires a multidisciplinary approach to mitigate device-specific risks like iatrogenic atrial septal defects.
Synapse has enriched 10 related papers. Consider them for comparative context: